Results 81 to 90 of about 6,880 (180)

Comparison of Structural Changes in Nodding Syndrome and Other Epilepsies Associated With Onchocerca volvulus. [PDF]

Neurol Neuroimmunol Neuroinflamm, 2023
Mazumder R, Lubowa SK, Salamon N, Jackson NJ, Kawooya M, Akun PR, Anguzu R, Ogwang RJ, Kubofcik J, Nutman T, Marsh K, Newton C, Vincent A, Idro R.   +13 more
europepmc   +1 more source

Onchocerciasis-associated epilepsy: an explorative case-control study with viral metagenomic analyses on <i> </i> <i>Onchocerca volvulus</i>. [PDF]

F1000Res, 2023
Hadermann A, Jada SR, Sebit WJ, Deng T, Bol YY, Siewe Fodjo JN, De Coninck L, Matthijnssens J, Mertens I, Polman K, Colebunders R.   +10 more
europepmc   +1 more source

Programmatic implications of the efficiency of uptake of Onchocerca volvulus microfilariae by Simulium sp. vectors. [PDF]

Int Health
Boakye DA, Osei-Atweneboana MY, Atta SK, Larbi IA, Mackenzie CD.   +4 more
europepmc   +1 more source

Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection. [PDF]

PLoS Negl Trop Dis, 2022
Tan B, Opoku N, Attah SK, Awadzi K, Kuesel AC, Lazdins-Helds J, Rayner C, Ryg-Cornejo V, Sullivan M, Fleckenstein L.   +9 more
europepmc   +1 more source

Development and Validation of an ELISA to Detect Antibody to Onchocerca volvulus Infection Using Mammalian Expressed Recombinant Ov16. [PDF]

Am J Trop Med Hyg
Ossai S, Wang Y, Elder ES, Wickens K, Won KY, Secor WE, Handali S.   +6 more
europepmc   +1 more source

Histopathological evaluation of Onchocerca volvulus nodules by microscopy and by digital image analysis for the study of macrofilaricidal drug efficacy. [PDF]

Front Med (Lausanne), 2023
Fischer K, Dubben B, Debrah LB, Kuehlwein JM, Ricchiuto A, Debrah AY, Hoerauf A, Weil GJ, Fischer PU, Klarmann-Schulz U.   +9 more
europepmc   +1 more source

Effects of emodepside on single-channel properties of Onchocerca volvulus SLO-1A (BK) potassium channels. [PDF]

Parasit Vectors
Njeshi CN, Choudhary S, McHugh MA, Kashyap SS, Robertson AP, Martin RJ.   +5 more
europepmc   +1 more source

Multimodal biomarker discovery for active Onchocerca volvulus infection. [PDF]

PLoS Negl Trop Dis, 2021
Lagatie O, Njumbe Ediage E, Van Roosbroeck D, Van Asten S, Verheyen A, Batsa Debrah L, Debrah A, Odiere MR, T'Kindt R, Dumont E, Sandra K, Dillen L, Verhaeghe T, Vreeken R, Cuyckens F, Stuyver LJ.   +15 more
europepmc   +1 more source

Helminth Antigens Modulate Virus-Induced Activation of CD154 (CD40L) Expression on T Cells in <i>Onchocerca volvulus</i>-Infected Individuals. [PDF]

Pathogens
Fogang BAN, Arndts K, Adjobimey T, Owusu M, Opoku VS, Adu Mensah D, Boateng J, Osei-Mensah J, Meyer J, Klarmann-Schulz U, Horn S, Kroidl I, Debrah AY, Hoerauf A, Ritter M, Debrah LB.   +15 more
europepmc   +1 more source

Genome and proteome screening of Onchocerca volvulus reveal putative vaccine candidates. [PDF]

Mol Biomed, 2021
Sheyin A, Gbem TT, Gaiya DD, Nok JA.
europepmc   +1 more source